Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 10, Number 28, November 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book review

Review article

Progress in the Development of Melanocortin Receptor Selective Ligands
pp. 3443-3479(37)
Authors: Irani, Boman G.; Holder, Jerry R.; Todorovic, Aleksandar; Wilczynski, Andrzej M.; Joseph, Christine G.; Wilson, Krista R.; Haskell-Luevano, Carrie

Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity
pp. 3481-3504(24)
Authors: Pei, Zhonghua; Liu, Gang; Lubben, Thomas H.; Szczepankiewicz, Bruce G.

New Pharmacological Perspectives and Therapeutic Potential of PPAR-ggr Agonists
pp. 3505-3524(20)
Authors: la Lastra, C. A.d.; Sanchez-Fidalgo, S.; Villegas, I.; Motilva, V.

Thyroid Hormone Ligands and Metabolic Diseases
pp. 3525-3532(8)
Author: Malm, Johan

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A